There is no caste in blood - Edwin Arnold
Ben Franklin famously wrote that “in this world, nothing can be said to be certain, except death and taxes”. What he didn’t mention, despite being 83 years old, was a third, almost inevitable eventuality: ageing.
Depending on when in history and where on the planet you look, ageing is variously considered desirable – bringing with it wisdom and status – or as something to be feared, eliminated, or at least delayed as long as possible.
In the 16th to 18th centuries, Western societies believed old age was a time of considerable worth. But since the 19th century we have sought ways to eliminate or minimise the effects of ageing.
Even in the time of Herodotus (the fifth century), there were stories of a “Fountain of Youth” located far away in the land of the Ethiopians, whose waters would bring youth and vigour to those who drank from it.
Blood is a potent symbol of life and of death. It is hardly surprising, then, that this incredible fluid is linked to the search for eternal youth in literature, legend, magic and medicine.
Recent scientific studies have claimed, almost vampire-like, that transfusions of blood from teenagers can help delay or reverse the ageing process. Where do these claims come from? Do they stack up? And how long will it be before we have the power to stave off what now is inevitable?
The first blood transfusion from one human to another is reported to date from 1492, for Pope Innocent VIII.
There is some discussion as to whether this was an attempt at a blood transfusion as we understand it today, or some other form of administration of blood (such as oral), given that the theory of circulation of blood was first published in 1628, some 150 years later.
Sources from 1873 stated:
All the blood of the prostrate old man should pass into the veins of a youth who had to yield up his to the Pope.
But earlier reports, from 1723, were less specific:
Three ten-year-old boys died because blood had been taken from their veins … in an attempt to cure the Pope.
Whatever the truth of the treatment, the pope did not recover, and neither did the boys. Here, at what is arguably the start of transfusion history, we can already see the lure of the belief in the power of young blood.
Fast forward to 2017 and the reputation of “young blood” is moving into the world of big business.
A company called Alkahest, based on work by Tony Wyss-Coray, a neurobiologist studying Alzheimer’s disease at Stanford University, is spruiking the results of a trial where plasma from young donors (aged 18-30) was transfused into patients with dementia.
Eighteen patients aged between 54 and 86 with mild to moderate Alzheimer’s disease were enrolled in the trial. They were infused with plasma (or placebo, in a control group) twice a week for four weeks.
Thankfully the trial was more successful than Pope Innocent VIII’s treatment. None of the patients showed any ill-effects, but neither did they show any improvement in tests of thinking ability. They did, however, demonstrate some improvement in tests that assessed their daily living skills.
At almost the same time, controversial trials by a company named Ambrosia (“food of the Gods” depicted as conferring immortality) are transfusing plasma from people aged 16-25 into people aged 35-92.
Despite the experimental nature of this treatment, participants are paying US$8,000 each to be included in the trial, for which there is no control group.
These factors make it virtually impossible to interpret the results, because people in the trial may “feel better” merely through having paid money for a treatment they believe is going to work.
Jesse Karmazin presented the results of the study so far at the Recode technology conference in Los Angeles in mid-2017. Ambrosia’s scientists examined the levels of various molecules, believed to be predictive of cancer or Alzheimer’s disease, in the blood of people who had been treated. They found that those who had been treated with young blood had lower levels of several proteins known to be involved in disease, namely carcinoembryonic antigens (which increase in cancer patients) and amyloid (which forms plaques in the brain in Alzheimer’s disease patients).
However, the long-term significance of these changes is unclear.
The science of stealing youth
Science has come a long way since Pope Innocent VIII, so what has led these modern scientists to try what appears to be a modern version of a very similar experiment?
The roots of both these companies lie in experiments in “parabiosis” (from Greek par meaning alongside, and bios meaning life) – a technique that dates back to the 1864 physiologist Paul Bert.
Bert surgically spliced animals together in his lab, so that two animals shared a single blood supply. This grizzly practice provides an opportunity to find out how soluble blood factors affect various bodily functions.
A group at Stanford University, led by Thomas Rando and including Irina Conboy, found in 2005 that when they joined the bodies and circulations of old and young mice, the muscle and liver cells in the old mice were able to regenerate as well as those in their younger counterparts.
Several experimental avenues led the researchers to conclude that the factor involved was circulating in the blood, although its identity was not known.
In 2007, Tony Wyss-Coray analysed the plasma proteins of patients with Alzheimer’s disease along with those from healthy people over a number of years. He found that levels of proteins in the blood change with age, some increasing, others decreasing.
His doctoral student at the time, Saul Villeda, looked at effects of parabiosis on the brain and found that the old mice in the pairs enjoyed more brain connection, and the brains of the young mice physically deteriorated.
But it was hard to test how well these brains worked in practice, because measuring an old mouse’s ability to find its way through a maze is difficult when it is physically attached to a young mouse, who may be leading the way!
There are other problems with the interpretation of parabiosis experiments. Old animals have access to the effects of younger organs, and their brains may also benefit from the environmental enrichment of being paired with a younger animal.
The search was on for what factor or factors may be responsible for the dramatic effects seen in parabiosis experiments, and to find if their rejuvenating effects could be replicated without the inconvenience of sharing a circulatory system. There are a few molecular suspects so far.
A protein known as GDF 11 is one contender for the title of “youth protein”. In 2013, researchers Amy Wagers and Richard Lee found that this protein from the blood of young mice can reverse the symptoms of heart failure in older mice. A year later they showed that GDF 11 appeared to act on skeletal muscle stem cells and enhance muscle repair.
Other studies have disagreed, suggesting that GDF 11 in fact increases with age and inhibits muscle repair. There are several technical reasons why these studies differ, and further studies may shed light on the role of GDF 11 and similar proteins.
In 2014, researchers Saul Villeda, Tony Wyss-Coray and their team found that exposing an old mouse to young blood can decrease apparent brain age. The effects were seen not only at the molecular level but also in the structures of the brain and in several measures of learning and memory.
In this case, a specific protein in the brain known as Creb (cyclic AMP response binding element) controlled the effects, although the stimulating factor in the blood was not identified.
The development and control of the brain involves numerous molecular signals, and a recent study has found yet another link between young blood and brain development. A protein in the brain, Tet2, declines with age, but mice whose brains have been given a boost of Tet2 are able to grow new brain cells and they improve at mouse-learning tasks.
The presence of young blood can provide such a boost in Tet2 because, in these experiments, old mice who are joined to young mice in a parabiosis have an increase in Tet2 in their brain. This provides yet another clue to the mechanism by which young blood acts on the brain.
Youth proteins v elder proteins
While old mice show benefit from transfusions of young mouse blood, the opposite is also true: young mice show signs of ageing when exposed to their elder’s blood. It appears there are not just “youth proteins” present in young blood, but also “elder proteins” in the blood of older animals.
In 2016, Irina Conboy’s research team used a blood-exchange technique between old and young mice, without surgically joining them. The results of this method would be easier to translate into a human medical setting than parabiosis, as it resembles exchange transfusions that are already used medically.
When they received old blood, the muscle strength of young mice decreased and the growth of their brain cells slowed down.
A protein known as B2M (beta-2-macroglobulin) may be involved in this process, although it does not appear to be elevated with age – possibly acted on by another signal from older blood.
Hanadie Yousef at Stanford University has identified a protein called VCAM1 that increases with age and causes signs of ageing when injected into young mice. What’s particularly interesting is that, in her studies, an antibody to VCAM1 can block these effects.
Quest for targeted therapies
So, where does this lead us today? Can teenagers full of young blood rest safely from elderly vampiric super-villains?
It seems that, rather than being the stuff of myth and magic, there are indeed factors in the blood that change with age: some that increase, some that decrease. Research has started to discover how some of these may work at a cellular level in muscles, organs and, in particular, the brain, as we age.
One day these discoveries may lead to rational and targeted therapies for a variety of conditions.
What is certain is that human plasma contains a vast array of active molecules, many of which are already in medical use. Donated plasma has been used for decades to fight disease, control bleeding and help with certain chronic neurological disorders.
Fortunately for us all, plasma from people of all ages can be used in these treatments.
Source: David Irving, Young blood: magic or medicine?, The Conversation, March 15, 2018.
Blood is fascinating. Many people learn at school that its function is to transport oxygen and nutrients around the body and remove waste products. But blood has many more functions, including defence against pathogens, regulating our temperature, and keeping important internal chemicals and nutrients balanced.
Here are some other things you might not know about blood.
They’re helping sick people in emergencies. But some think they’re a $12 million mistake.
There are “blue bloods,” as in aristocrats or people who are socially prominent. There is Blue Bloods, the television series. Then, there’s the woman who actually had blue blood, as described in a case report in the New England Journal of Medicine.
Many Soviet children grew up loving the sweetness, texture, and slight metallic twang of Hematogen bars—without knowing what was in them.
About 30 percent of all women report heavy menstrual periods at some point during their reproductive years. Up to 15 percent of these have an underlying bleeding disorder and yet most have never been diagnosed, leaving thousands of women to suffer from a treatable problem.
New information has enabled researchers like myself to reevaluate our understanding of the role of platelets in cancer. Until recently, relatively few studies have observed a protective role of platelets in cancer. While there is substantial evidence linking intact platelets to promoting cancer, the dual pro- and anti-cancerous roles of platelets raise some fascinating questions about both intact platelets and the microparticles that they release.
For centuries scientists have sought an artificial substitute for blood. Equipped with modern nanotechnology and a humbler strategy, bioengineers think they’re closer than ever.
Blood can be racially or ethnically specific, so having more blood donors in certain groups can be crucial for saving the lives of patients who share their backgrounds.
It's the most primordial substance there is, so maybe it was inevitable that it would become a commodity more valuable than oil.
Cheap, easy tests will replace expensive medical screenings and make health care more accessible for people everywhere.
Just as a village can’t grow into a city without some form of transport (road, rail or river) that provides necessary interconnections for it to flourish, living things are limited in the size they can reach unless they have some form of circulatory system to transport nutrients and remove waste.
While blood is essential for human life, there are many things that can go wrong. And as it travels around the body and flows through every organ, problems in the blood can have wide-ranging implications for our health. There are countless problems that can occur in this vital fluid; here, we’ll have a look at the most common - bleeding disorders, clotting disorders and blood cancers.
Scientists have made a new biomaterial that mimics the function of platelets, components of blood that help with clotting, or sealing, a wound.
Heavy bleeding is one of the most common problems women report to their doctors...
But until we hit that deal breaker, a future where people suffering from genetic blood disorders will soon have their pesky mutations Crispr’d out of their DNA for good is coming into clearer view.
The FDA is considering lifting restrictions on blood donation based on sexual orientation. If they do, increasing the blood supply will be only the most straightforward benefit.
The core material in Grouin-Rigaux’s products is a bone or skin glue, which is created by prolonged boiling of animal connective tissues which contain collagen fibers. This glue is then colored with either “blood powder” or “bone char” pigment.
The maternal mortality rate in the state is a third of the American average. Here's why.
In traditional Chinese medicine several “black foods” are believed to be a good source of nutrients and beneficial for blood production. A recent paper in the British Journal of Nutrition have evaluated several “black foods” and have found that black soybeans (Glycine max) affect a key regulator in iron metabolism and may be beneficial for certain types of blood disorders.
Here we look at how blood transfusions started as an experiment four centuries ago, and became a modern-day life saver.
Blood is red, and a surgeon will tell you our veins too are red, they only look blue when we see them through our skin. But why?
The answer depends on a number of things, including how your eyes perceive colour, how light behaves when it contacts your body, and the special properties of blood.
New research published this week by two teams of scientists confirmed what Bram Stoker and countless philosophers, scientists, and cannibals have long posited — there’s an indisputable relationship between blood and aging.
When blood escapes the body or laboratory, it is particularly disturbing and unruly. We speak of spilt blood as contaminated, infected, impure. Controlled blood-letting is a symbol of masculinity; menstruation a sign of abjection, and gay men’s blood is to be feared, to say nothing of the anxiety of intermingling blood between people, races and species. To work with blood can raise ethical issues, but is equally an opportunity to shed light on the source of many prejudices and misconceptions.
Amid new pathogens and cost pressures, efforts are under way to keep patients safe.
Since 2008, plasma pharmaceuticals have leapt from $4 billion to a more than $11 billion annual market. Donors desperate for the cash incentive from high-frequency "plassing" may be putting their health, and the public's, at risk.
Desperate people can make $30 donating plasma, up to 104 times a year, in this $20 billion industry.
The tradition of claiming a Cherokee ancestor continues into the present. Today, more Americans claim descent from at least one Cherokee ancestor than any other Native American group.
Getting dizzy and fainting at the sight of someone else's blood doesn't seem to be the most, uh, evolutionarily appropriate response. How's that going to help you when you're trying to take down a buffalo? And despite it being relatively common--3 to 4 percent of people suffer from blood phobia or a related disorder--the symptoms of it are totally different from most phobias: phobics' blood pressure and heart rate will rise then drop when they see blood, as opposed to the just-heart-racing caused by most fears. So what gives?
Your blood is red. That's the case for most animals on Earth.
But there are exceptions. Certain types of marine worms found in shallow ocean waters around the world have green and purple blood. And the common horseshoe crab has bright blue blood that gets harvested for bacterial-testing kits used by pharmaceutical companies.
Blood is a potent symbol of life and of death. It is hardly surprising, then, that this incredible fluid is linked to the search for eternal youth in literature, legend, magic and medicine.
The bleeding disorders magazine.
Blood is a weekly medical journal published by the American Society of Hematology. It was founded by Dr. William Dameshek, the researcher credited with describing the concept of myeloproliferative diseases and participating in the first studies of nitrogen mustard in various blood malignancies, in 1946, and has since been in continuous publication.
Our hope is, as you digest the information presented on BloodBook.com, that you become aware of the benefits of personal Blood testing, at least annually, if possible, and also that you consider autologous Blood donation and storage alternatives. Beyond that, we seek to present, in an easy-to-use format, useful and accurate facts about Blood, the Blood supply and closely related subjects.
People may be affected by many different types of blood conditions and blood cancers. Common blood disorders include anemia, bleeding disorders such as hemophilia, blood clots, and blood cancers such as leukemia, lymphoma, and myeloma.
Hemoglobal® began on the island of Sri Lanka following years of work in research and care of children in thalassemia, which is the most common blood disorder in Asia. Governed by the conviction that country of birth or family income should not determine the life or death of a child, Dr. Nancy Olivieri and Professor David Weatherall founded Hemoglobal® to help provide children in Asia with improved care to preserve their lives, and quality of life.
OneBlood is a not-for-profit 501(c)(3) community asset responsible for providing safe, available and affordable blood to more than 200 hospital partners.
The Bleeding Disorder Foundation of Washington (BDFW) is a volunteer-based non-profit that gives a voice to those with a bleeding disorder, creates awareness of our cause statewide and influences those that can to support our cause.
A community where survivors, recovering victims, families, friends, loved ones and advocates can come together to find encouragement, empowerment, enrichment and education to aid in the fight against not only the occurrence of blood clots, including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), but the devastating and far-reaching effects as well.
Iron Disorders Institute’s vision is that no one should suffer or die prematurely because of Iron-Out-of-Balance™. IDI exists so that people with iron disorders receive early, accurate (complete) diagnosis, appropriate treatment and are equipped to live in good health.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
Blood disorders - such as sickle cell disease, anemia, and hemophilia - affect millions of people each year in the United States, cutting across the boundaries of age, race, sex, and socioeconomic status. Men, women, and children of all backgrounds live with the complications associated with these conditions, many of which are painful and potentially life-threatening.
Bleeding disorders are usually taken to mean coagulopathies with reduced clotting of the blood but also encompass disorders characterised by abnormal platelet function or blood vessel walls that result in increased bleeding. Bleeding disorders may result from faults at many different levels in the coagulation cascade. They can range from severe and life-threatening conditions, such as haemophilia A, to much more mild variants. Some bleeding symptoms (eg, bruising without obvious cause, nosebleeds and heavy menstrual bleeding) are quite common in the general population and there is phenotypic variation even among individuals with defined bleeding problems. Investigation of mild bleeding problems often fails to provide a diagnosis.
There are many kinds of bleeding disorders. The two most common are von Willebrand disease (VWD) and hemophilia.